MEREDITH DVORAK: Open Payments
NPI 1083387567 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 59 payments from 14 companies in 2025. Trend: 2023 $827 · 2024 $673 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $352 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $205 |
| Janssen Pharmaceuticals, Inc | 5 | $198 |
| Axsome Therapeutics, Inc. | 15 | $177 |
| ABBVIE INC. | 4 | $74 |
| Tris Pharma Inc | 2 | $51 |
| Alkermes, Inc. | 2 | $50 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: CAPLYTA, SPRAVATO, FANAPT, Auvelity, HETLIOZ, VRAYLAR, Dyanavel XR, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
